Patent ID: 6846816

Claim:
A method for treating a patient having cancer, said method comprising administering to said patient: a) a first compound having the formula (I): or a pharmaceutically acceptable salt thereof, wherein R 2 is selected from the group consisting of: R 10 is selected from the group consisting of: each of R 1 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 is, independently, H, OH, F, OCF 3 , or OCH 3 ; and W is selected from the group consisting of: and b) a second compound having the formula (II): or a pharmaceutically acceptable salt thereof, wherein each of Y and Z is, independently, O or N; each of R 11 and R 12 is, independently, H, Cl, Br, OH, OCH 3 , OCF 3 , NO 2 , and NH 2 ; n is an integer between 2 and 6, inclusive; and each of R 13 and R 14 is, independently, selected from the group consisting of: wherein said first and second compounds are administered simultaneously or within 14 days of each other in amounts sufficient to treat said patient.